- Home
- ITRG vs BNTC Comparison
ITRG vs BNTC Comparison
Compare ITRG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | BNTC |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 586.3M | 411.4M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ITRG | BNTC |
|---|---|---|
| Price | $2.88 | $11.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.13 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 3.2M | 112.3K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $67.34 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $45.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.26 | $9.85 |
| 52 Week High | $4.87 | $17.15 |
Technical Indicators
Market Signals| Indicator | ITRG | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 41.97 | 48.61 |
| Support Level | $2.60 | $9.91 |
| Resistance Level | $3.24 | $13.27 |
| Average True Range (ATR) | 0.19 | 0.58 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 60.48 | 55.94 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.